Imunon, Inc. (IMNN)
NASDAQ: IMNN · Real-Time Price · USD
3.835
+0.035 (0.92%)
Jan 14, 2026, 12:05 PM EST - Market open

Imunon Market Cap

Imunon has a market cap or net worth of $13.04 million as of January 14, 2026. Its market cap has increased by 13.39% in one year.

Market Cap
13.04M
Enterprise Value
8.43M
1-Year Change
13.39%
Ranking
Category
Stock Price
$3.84

Market Cap Chart

Since March 1, 1999, Imunon's market cap has decreased from $37.70M to $13.04M, a decrease of -65.41%. That is a compound annual growth rate of -3.87%.

History

DateMarket Cap% Change
Jan 13, 202611.70M-
Dec 31, 202511.70M-15.22%
Dec 31, 202413.80M115.63%
Dec 29, 20236.40M-36.00%
Dec 30, 202210.00M-78.59%
Dec 31, 202146.70M75.56%
Dec 31, 202026.60M-31.62%
Dec 31, 201938.90M47.35%
Dec 31, 201826.40M-38.60%
Dec 29, 201743.00M444.30%
Dec 30, 20167.90M-82.29%
Dec 31, 201544.60M-4.09%
Dec 31, 201446.50M-12.10%
Dec 31, 201352.90M-81.56%
Dec 31, 2012286.80M531.72%
Dec 30, 201145.40M73.95%
Dec 31, 201026.10M-34.09%
Dec 31, 200939.60M77.58%
Dec 31, 200822.30M-30.75%
Dec 31, 200732.20M57.07%
Dec 29, 200620.50M-52.87%
Dec 30, 200543.50M-52.51%
Dec 31, 200491.60M-52.76%
Dec 31, 2003193.90M367.23%
Dec 31, 200241.50M-26.29%
View and export this data all the way back to 1999. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
Eli Lilly and Company967.91B
Johnson & Johnson505.28B
AbbVie388.90B
UnitedHealth Group308.45B
AstraZeneca294.97B
Novartis AG274.30B
Merck & Co.271.01B
Novo Nordisk263.26B
Market Cap Rankings